List your tool

Head to head · 2026

Paige vs SOPHiA GENETICS

Pricing, free plans, ratings, features, pros and cons, side by side. Where one comes out ahead, we mark it.

Paige

Digital pathology AI co-pilot from Memorial Sloan Kettering researchers, acquired by Tempus in 2025

4.1Not listed

Visit Paige (opens Paige in a new tab)

SOPHiA GENETICS

AI genomic analytics at 98-99% accuracy, deployed across 1,000+ healthcare institutions in 75+ countries - 2.6…

3.9Not listed

Visit SOPHiA GENETICS (opens SOPHiA GENETICS in a new tab)

Who comes out ahead

Based only on the facts in our directory. The right pick still depends on the job you need done.

  • Lower starting price

    Not comparable

    Not comparable: Paige does not list a price

  • Free plan

    Tie

    Neither has one

  • Higher rating

    Paige

    4.1 against 3.9

  • Same job?

    Yes

    Both are Healthcare AI tools

Side by side

Compared onPaigeSOPHiA GENETICS
Our rating4.1Better3.9
Starts atNot listedNot listed
Free planNoNo
CategoryHealthcare AIHealthcare AI
PlansSee pricingSee pricing
Key features
  • Paige Alba AI co-pilot for digital pathology tissue-slide analysis
  • Cancer diagnosis, tissue subtyping, and molecular biomarker discovery support
  • Founded in 2017 by researchers from Memorial Sloan Kettering Cancer Center
  • Acquired by Tempus in August 2025, continuing under its own brand
  • Enterprise deployment with dedicated support for hospital and lab pathology teams
  • SOPHiA DDM - AI genomic and radiomic analysis platform
  • 98-99% accuracy across 2.6M+ analyzed genomic profiles
  • Oncology coverage - solid tumors, blood cancers, hereditary cancers, liquid biopsy
  • Rare and inherited disorder analysis
  • HIPAA/GDPR-compliant cloud infrastructure
Pros
  • Research pedigree from Memorial Sloan Kettering lends real clinical credibility
  • Tempus backing adds financial resources and precision-medicine data integration
  • Deep oncology pathology specialization outperforms general-purpose medical imaging AI
  • Accuracy claims are backed by scale (2.6M+ profiles), not a small validation sample
  • Deployed across a genuinely large, verifiable institutional network (1,000+ sites, 75+ countries)
  • Covers both oncology and rare/inherited disorder use cases
Cons
  • Enterprise-only pricing requires a sales conversation before evaluation
  • Now part of a larger company, a real change from its independent-startup years
  • Narrow pathology focus means it's not a fit for non-oncology diagnostic workflows
  • No published pricing - an institutional sales process
  • Built for healthcare institutions, not individual practitioners or patients directly
  • Requires integration into existing clinical genomics/pathology workflows
CompanyPaige, founded 2017SOPHiA GENETICS

Prices come from each vendor's pricing page, last checked 20260824. Check the vendor before you buy.

FAQ

Questions people ask

Is Paige better than SOPHiA GENETICS?

In our reviews Paige scores 4.1 and SOPHiA GENETICS scores 3.9. The better pick depends on the job. Paige: Digital pathology AI co-pilot from Memorial Sloan Kettering researchers, acquired by Tempus in 2025. SOPHiA GENETICS: AI genomic analytics at 98-99% accuracy, deployed across 1,000+ healthcare institutions in 75+ countries - 2.6 million-plus genomic profiles analyzed to date.

Which is cheaper, Paige or SOPHiA GENETICS?

Paige: see pricing. SOPHiA GENETICS: see pricing.

Do Paige and SOPHiA GENETICS have free plans?

Neither lists a free plan.

More comparisons